May 16, 2025 - 09:15

The world's largest cloud computing company has announced plans to invest £8 billion in new data centers across the UK over the next four years. This significant investment underscores the growing demand for data processing capabilities, particularly as artificial intelligence (AI) technologies continue to advance.
The company's leadership emphasizes that a robust energy infrastructure is crucial to support the increasing power requirements of these data centers. In particular, they highlight the need for more nuclear energy to ensure a stable and sustainable power supply. As AI applications become more prevalent in various sectors, the demand for reliable and efficient energy sources is expected to rise sharply.
The proposed expansion of data centers is seen as a strategic move to enhance the UK's position in the global tech landscape. By focusing on nuclear energy, the company aims to contribute to a greener energy future while meeting the burgeoning needs of AI and cloud computing. This initiative is expected to create numerous job opportunities and stimulate economic growth in the region.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...